The U.K. company presented findings that its 360 e-Lung technology could potentially speed up the diagnosis of progressive pulmonary fibrosis by nearly two years in more than half of the patients ...

Nerandomilast is an oral, preferential PDE4B inhibitor approved in China for the treatment of adult patients with IPF and PPF. It was also approved by the U.S. Food and Drug Administration (FDA) for ...

When Amy was first diagnosed with scleroderma, she never imagined it would lead to a lifelong journey with lung disease.

Key Takeaways Current lung cancer screening guidelines restrict eligibility to a select group of longer-term smokersA new study finds that under the guidelines, almost two-thirds of lung cancer ...

Study in Lancet Digital Health represents the largest real-world evaluation of stroke AI imaging, encompassing data from more ...

We present the case of an 82-year-old woman with progressive dyspnea, hoarseness, and dysphagia due to a large substernal ...

Under current screening guidelines, almost two-thirds of Americans with lung cancer would not have qualified for required scans, researchers said.

Two mutated alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in the autosomal recessive ...

The three absences paved the way for the total of 71 in the season, which involved 31 different players, five of whom have ...

A male in his 50s presented to the renal department with a diagnostic challenge of an unexplained kidney injury.

Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue.